Home/Pipeline/CNRT-based Therapies

CNRT-based Therapies

Immunological Disorders

ResearchActive

Key Facts

Indication

Immunological Disorders

Phase

Research

Status

Active

Company

Veroscience

About Veroscience

VeroScience, founded in 2003 and based in Raleigh, NC, is a private biotech leveraging circadian neuroendocrine science to develop novel therapeutics. The company's core platform, Circadian Neuroendocrine Resetting Therapy (CNRT), underpins its approved product for type 2 diabetes (Cycloset) and a pipeline exploring applications in pediatric diabetes and oncology. Operating as a small, efficient organization, VeroScience advances its programs through nationwide preclinical/clinical research and strategic academic and industry collaborations.

View full company profile

Therapeutic Areas

Metabolic Diseases Immunological Disorders Oncology

Other Immunological Disorders Drugs

Drug	Company	Phase	Status
Not publicly disclosed	Sanyou Biopharmaceuticals	Preclinical	Active
Undisclosed Immunology Programs	BridGene Biosciences	Discovery	Active